FDA Brief

Warning letters Drugs

FDA warning letter to

C&G Laboratorios SA de CV

High riskIssued Apr 26, 2021Posted May 11, 2021Center for Drug Evaluation and Research

C&G Laboratorios of Mexico shipped hand sanitizer labeled 70% ethanol that contained 65% methanol, a toxic substitute.

What happened

FDA tested a batch of HAND SANITIZER DISINFECTANT GEL made at the firm's Mexico City facility after it was detained at the U.S. border and refused admission. The batch labeled 70% ethanol contained on average only 1.1% ethanol and 65% methanol, a substance FDA says is not an acceptable hand sanitizer ingredient because it is toxic on skin and can cause blindness, nervous system damage or death if swallowed. FDA placed all of the firm's drugs on Import Alert 66-78 on October 9, 2020 and publicly warned consumers on October 1, 2020.

What FDA found

  1. The labeled active ingredient, ethanol, was replaced wholly or partly with methanol, which is dangerous on skin or if swallowed.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The substitution shows the firm's quality assurance is not working as required by current good manufacturing practice (CGMP, the FDA's required quality standards for drug making).

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer is a new drug sold without FDA approval and does not fit any allowed over-the-counter monograph.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  4. The label is false or misleading: it calls the product a disinfectant (meant for surfaces) and claims 70% ethanol when far less was present and methanol was not declared.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  5. The label does not list methanol as an ingredient.

    FD&C Act section 502(e)(1)(A), 21 U.S.C. 352(e)(1)(A)
  6. The product is dangerous to health when used as labeled, and it is a nonprescription drug that does not meet the requirements for marketing under section 505G.

    FD&C Act sections 502(j) and 502(ee), 21 U.S.C. 352(j) and 352(ee)

What FDA wants

Respond in writing within 15 working days with a detailed investigation into how ethanol was replaced with methanol, a list of all raw materials and suppliers, a list and full reconciliation of all hand sanitizer batches shipped to the U.S., and complete batch records. FDA also strongly recommends hiring a qualified CGMP consultant before making drugs for the U.S. market again.

Who should pay attention

  • retailers and distributors that import or sell Mexican-made hand sanitizer
  • brands and private-label buyers that source finished sanitizer from this contract manufacturer
  • consumer safety and quality teams tracking methanol-contaminated hand sanitizer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk